HCPCS Level IIdrugActive
J9272
Inj, dostarlimab-gxly, 10 mg
BETOS: O1D
Effective: 2022-01-01
Description
Injection, dostarlimab-gxly, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Jemperli
Manufacturer
GlaxoSmithKline LLC
HCPCS Dosage
10 MG
Billing Units
50.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.